Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
For IBD patients, family history of colorectal cancer matters — a lot. A large Swedish study found that having two or more first-degree relatives with colorectal cancer (CRC) nearly triples the risk in IBD patients, while having a relative with early-onset CRC raises risk only modestly. The findings challenge current guidelines that heavily emphasize early-onset family history as the key risk marker.
For people living with inflammatory bowel disease (IBD), a family history of colorectal cancer (CRC) is a serious red flag — but the type of family history matters more than previously thought. A large Swedish cohort study tracking over 124,000 IBD patients and 1.2 million matched comparators from 1996 to 2023 found that having two or more first-degree relatives diagnosed with CRC was the strongest predictor of elevated CRC risk in IBD patients, nearly tripling it.
Interestingly, having a relative diagnosed with early-onset CRC (before age 50) — the factor currently emphasized in international guidelines — was linked to only a modest, statistically non-significant risk increase. This directly challenges existing AGA and ECCO recommendations, which call for annual colonoscopy surveillance for IBD patients with a first-degree relative diagnosed before age 50.
Key Takeaways:
Why it matters: Current surveillance protocols may be misallocating resources by focusing on early-onset family history rather than the number of affected relatives. Researchers say future guidelines should integrate family history with other IBD-specific risk factors to enable more personalized CRC screening.
